HDAC2 may also be a potential biomarker for the prognosis of tumor progression in squamous cell carcinoma of the oral cavity [326], esophageal squamous cell carcinoma [327], gallbladder carcinoma [328], and breast carcinoma [329]. The gene discussed is HDAC2; the disease is neoplasm.